scPharmaceuticals Inc. (SCPH) Social Stream
SCPHARMACEUTICALS INC (SCPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SCPH.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-12-16 | 3 | $15 | $6 | $10.666 | $5.74 | 85.82% |
2022-03-23 | 3 | $15 | $5 | $10.333 | $5.74 | 80.02% |
2022-05-17 | 3 | $15 | $6 | $10.667 | $5.74 | 85.84% |
2022-10-03 | 3 | $15 | $6 | $10.333 | $5.74 | 80.02% |
2022-10-14 | 3 | $15 | $11 | $13 | $5.74 | 126.48% |
2022-10-28 | 4 | $15 | $11 | $13.25 | $5.74 | 130.84% |
2022-11-28 | 4 | $18 | $12 | $14.25 | $5.74 | 148.26% |
2022-12-02 | 5 | $25 | $12 | $16.4 | $5.74 | 185.71% |
The Trend in the Analyst Price Target
Over the past 15 months, SCPH's average price target has gone up $3.4.
Over the past 36 weeks, SCPH's average upside potential has been 114.1%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-23 | 3 | 15 | 5 | 10.333 | 5.52 | 87.19% |
2022-05-17 | 2 | 15 | 6 | 10.667 | 4.78 | 123.16% |
2022-08-09 | 3 | 15 | 6 | 10.333 | 5.50 | 87.87% |
2022-10-03 | 3 | 15 | 6 | 10.333 | 6.34 | 62.98% |
2022-10-28 | 4 | 15 | 11 | 13.250 | 5.32 | 149.06% |
SCPH Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
SCPH's average broker recommendation rating improved by 1 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SCPH has a greater number of analysts covering the stock than 138.41% of all US stocks.
- SCPH has a higher average analyst price target than 159.97% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, SCPHARMACEUTICALS INC's variance in analysts' estimates is lower than -759.35% of them.
- In the context of stocks in the micro market cap category, SCPHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 421.83% of them.
In the Pharmaceutical Products industry, AYTU, CLRB, and ALRN are the three stocks most similar to SCPHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SCPH a Buy, Hold or Sell? See the POWR Ratings now!